Breaking News

Lonza Ends Talks To Buy Patheon

Lonza has withdrawn its offer to acquire Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza has withdrawn its offer to acquire Patheon. Patheon’s Special Committee of Independent Directors and Lonza also mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon. When Lonza’s proposal was made public in August, JLL Patheon Holdings LLC, which holds 57% of the Patheon’s outstanding restricted voting shares, announced that it rejected the proposal and would not support any transaction involving a sale of i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters